{"pmid":32478697,"title":"COVID-19 in the Americas: We Are in This Together.","text":["COVID-19 in the Americas: We Are in This Together.","COVID-19 has upended the world's healthcare infrastructures and its economies, casting a glaring light on the failings and flaws already in place, all suffered unequally. This has forced leaders and the public at large to face the stark contrast between human society as it exists and the society that is possible, with both the world's majority and the planet leaping to the top of a new agenda...an agenda as urgently needed as a new vaccine.","MEDICC Rev","32478697"],"abstract":["COVID-19 has upended the world's healthcare infrastructures and its economies, casting a glaring light on the failings and flaws already in place, all suffered unequally. This has forced leaders and the public at large to face the stark contrast between human society as it exists and the society that is possible, with both the world's majority and the planet leaping to the top of a new agenda...an agenda as urgently needed as a new vaccine."],"journal":"MEDICC Rev","date":"2020-06-02T11:00:00Z","year":2020,"_id":"32478697","source":"PubMed","week":"202023|Jun 01 - Jun 07","weight":0,"_version_":1668437835031511041,"score":9.490897,"similar":[{"pmid":32238221,"pmcid":"PMC7156578","title":"Declining Public Health Protections within Autocratic Regimes: Impact on Global Public Health Security, Infectious Disease Outbreaks, Epidemics, and Pandemics.","text":["Declining Public Health Protections within Autocratic Regimes: Impact on Global Public Health Security, Infectious Disease Outbreaks, Epidemics, and Pandemics.","Public health emergencies of international concern, in the form of infectious disease outbreaks, epidemics, and pandemics, represent an increasing risk to the world's population. Management requires coordinated responses, across many disciplines and nations, and the capacity to muster proper national and global public health education, infrastructure, and prevention measures. Unfortunately, increasing numbers of nations are ruled by autocratic regimes which have characteristically failed to adopt investments in public health infrastructure, education, and prevention measures to keep pace with population growth and density. Autocratic leaders have a direct impact on health security, a direct negative impact on health, and create adverse political and economic conditions that only complicate the crisis further. This is most evident in autocratic regimes where health protections have been seriously and purposely curtailed. All autocratic regimes define public health along economic and political imperatives that are similar across borders and cultures. Autocratic regimes are seriously handicapped by sociopathic narcissistic leaders who are incapable of understanding the health consequences of infectious diseases or the impact on their population. A cross section of autocratic nations currently experiencing the impact of COVID-19 (coronavirus disease 2019) are reviewed to demonstrate the manner where self-serving regimes fail to manage health crises and place the rest of the world at increasing risk. It is time to re-address the pre-SARS (severe acute respiratory syndrome) global agendas calling for stronger strategic capacity, legal authority, support, and institutional status under World Health Organization (WHO) leadership granted by an International Health Regulations Treaty. Treaties remain the most successful means the world has in preventing, preparing for, and controlling epidemics in an increasingly globalized world.\"Honesty is worth a lot more than hope...\" The Economist, February 17, 2020.","Prehosp Disaster Med","Burkle, Frederick M","32238221"],"abstract":["Public health emergencies of international concern, in the form of infectious disease outbreaks, epidemics, and pandemics, represent an increasing risk to the world's population. Management requires coordinated responses, across many disciplines and nations, and the capacity to muster proper national and global public health education, infrastructure, and prevention measures. Unfortunately, increasing numbers of nations are ruled by autocratic regimes which have characteristically failed to adopt investments in public health infrastructure, education, and prevention measures to keep pace with population growth and density. Autocratic leaders have a direct impact on health security, a direct negative impact on health, and create adverse political and economic conditions that only complicate the crisis further. This is most evident in autocratic regimes where health protections have been seriously and purposely curtailed. All autocratic regimes define public health along economic and political imperatives that are similar across borders and cultures. Autocratic regimes are seriously handicapped by sociopathic narcissistic leaders who are incapable of understanding the health consequences of infectious diseases or the impact on their population. A cross section of autocratic nations currently experiencing the impact of COVID-19 (coronavirus disease 2019) are reviewed to demonstrate the manner where self-serving regimes fail to manage health crises and place the rest of the world at increasing risk. It is time to re-address the pre-SARS (severe acute respiratory syndrome) global agendas calling for stronger strategic capacity, legal authority, support, and institutional status under World Health Organization (WHO) leadership granted by an International Health Regulations Treaty. Treaties remain the most successful means the world has in preventing, preparing for, and controlling epidemics in an increasingly globalized world.\"Honesty is worth a lot more than hope...\" The Economist, February 17, 2020."],"journal":"Prehosp Disaster Med","authors":["Burkle, Frederick M"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32238221","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1017/S1049023X20000424","keywords":["autocratic regimes","crisis management","epidemics/pandemics","global public health","public health emergencies"],"topics":["Prevention"],"weight":1,"_version_":1666138490428981248,"score":125.07805},{"pmid":32426144,"pmcid":"PMC7218554","title":"Together we unite: the role of the Commonwealth in achieving universal health coverage through pharmaceutical care amidst the COVID-19 pandemic.","text":["Together we unite: the role of the Commonwealth in achieving universal health coverage through pharmaceutical care amidst the COVID-19 pandemic.","The world currently faces unprecedented health challenges as COVID-19 poses a huge threat to health systems, economies and societies as we know it. The events of the current COVID-19 pandemic have further emphasised existing issues within our health systems. There is no better time than now to come together in global solidarity to tackle these evolving threats of COVID-19 pandemic. The Commonwealth is an ideally placed network to tackle these global health challenges, with its wide-reaching networks of governmental, non-governmental and civil society organisations across all continents. Although the biennial Commonwealth Heads of Government Meeting (CHOGM) originally scheduled to take place in Kigali in Rwanda 22-27 June 2020 has been postponed in view of COVID-19, Commonwealth country discussions are continuing, centred on the CHOGM key theme of 'Delivering a Common Future: Connecting, Innovating, Transforming', and five subthemes of Information and Communications Technology (ICT) and Innovation; Trade; Environment; Governance and the Rule of Law; and Youth. The planned CHOGM and Commonwealth itself provides all members a timely platform to consider innovative ways to connect, innovate and transform healthcare to meet the needs of their populations. This commentary considers these five CHOGM subthemes and how member nations can be supported to achieve universal health coverage through optimising medicines use and outcomes, in the midst of a global pandemic in line with the global health agenda.","J Pharm Policy Pract","Chan, Amy Hai Yan","Rutter, Victoria","Ashiru-Oredope, Diane","Tuck, Chloe","Babar, Zaheer-Ud-Din","32426144"],"abstract":["The world currently faces unprecedented health challenges as COVID-19 poses a huge threat to health systems, economies and societies as we know it. The events of the current COVID-19 pandemic have further emphasised existing issues within our health systems. There is no better time than now to come together in global solidarity to tackle these evolving threats of COVID-19 pandemic. The Commonwealth is an ideally placed network to tackle these global health challenges, with its wide-reaching networks of governmental, non-governmental and civil society organisations across all continents. Although the biennial Commonwealth Heads of Government Meeting (CHOGM) originally scheduled to take place in Kigali in Rwanda 22-27 June 2020 has been postponed in view of COVID-19, Commonwealth country discussions are continuing, centred on the CHOGM key theme of 'Delivering a Common Future: Connecting, Innovating, Transforming', and five subthemes of Information and Communications Technology (ICT) and Innovation; Trade; Environment; Governance and the Rule of Law; and Youth. The planned CHOGM and Commonwealth itself provides all members a timely platform to consider innovative ways to connect, innovate and transform healthcare to meet the needs of their populations. This commentary considers these five CHOGM subthemes and how member nations can be supported to achieve universal health coverage through optimising medicines use and outcomes, in the midst of a global pandemic in line with the global health agenda."],"journal":"J Pharm Policy Pract","authors":["Chan, Amy Hai Yan","Rutter, Victoria","Ashiru-Oredope, Diane","Tuck, Chloe","Babar, Zaheer-Ud-Din"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32426144","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1186/s40545-020-00214-6","keywords":["chogm","commonwealth","heads of government","health","pandemic","pharmacists","pharmacy"],"locations":["Kigali","Rwanda"],"countries":["Rwanda"],"countries_codes":["RWA|Rwanda"],"topics":["Prevention"],"weight":1,"_version_":1667252837854216192,"score":112.75793},{"pmid":32162604,"title":"How Is the World Responding to the 2019 Coronavirus Disease Compared with the 2014 West African Ebola Epidemic? The Importance of China as a Player in the Global Economy.","text":["How Is the World Responding to the 2019 Coronavirus Disease Compared with the 2014 West African Ebola Epidemic? The Importance of China as a Player in the Global Economy.","This article describes similarities and differences in the response of governments and the international community to the current 2019 coronavirus disease (COVID-19) and the 2014 West African Ebola epidemic. It expresses the opinion that the speed and scale of the response to the 2019 COVID-19 are affected by the important role that China plays in the global economy. By contrast, insufficient and less timely action was initially undertaken in West African countries during the 2014 Ebola epidemic. It concludes by stating why preparedness for and response to all disease outbreaks, also in countries of lower economic importance, should become a priority in the global health agenda.","Am J Trop Med Hyg","Maffioli, Elisa M","32162604"],"abstract":["This article describes similarities and differences in the response of governments and the international community to the current 2019 coronavirus disease (COVID-19) and the 2014 West African Ebola epidemic. It expresses the opinion that the speed and scale of the response to the 2019 COVID-19 are affected by the important role that China plays in the global economy. By contrast, insufficient and less timely action was initially undertaken in West African countries during the 2014 Ebola epidemic. It concludes by stating why preparedness for and response to all disease outbreaks, also in countries of lower economic importance, should become a priority in the global health agenda."],"journal":"Am J Trop Med Hyg","authors":["Maffioli, Elisa M"],"date":"2020-03-13T11:00:00Z","year":2020,"_id":"32162604","source":"PubMed","week":"202011|Mar 09 - Mar 15","doi":"10.4269/ajtmh.20-0135","locations":["West African","China","West African","West African"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138492650913793,"score":97.81115},{"pmid":32435500,"pmcid":"PMC7225402","title":"A step towards gender equity to strengthen the pharmaceutical workforce during COVID-19.","text":["A step towards gender equity to strengthen the pharmaceutical workforce during COVID-19.","There is plenty of evidence to support that women leaders are needed in the health and pharmaceutical sectors, although most of the leadership positions in global health are predominantly occupied by men. This is a major challenge to global health policy. Gender diversity and inclusion within the pharmaceutical workforce is integral to optimal patient care. Women continue to be underrepresented in senior and leadership positions within pharmacy, despite outnumbering the men in the global pharmacy workforce. This commentary highlights the need towards gender equity and discusses the several key initiatives that are building momentum and making substantial progress towards this agenda in the pharmaceutical workforce.","J Pharm Policy Pract","Bukhari, Nadia","Manzoor, Mehr","Rasheed, Huma","Nayyer, Bismah","Malik, Madeeha","Babar, Zaheer-Ud-Din","32435500"],"abstract":["There is plenty of evidence to support that women leaders are needed in the health and pharmaceutical sectors, although most of the leadership positions in global health are predominantly occupied by men. This is a major challenge to global health policy. Gender diversity and inclusion within the pharmaceutical workforce is integral to optimal patient care. Women continue to be underrepresented in senior and leadership positions within pharmacy, despite outnumbering the men in the global pharmacy workforce. This commentary highlights the need towards gender equity and discusses the several key initiatives that are building momentum and making substantial progress towards this agenda in the pharmaceutical workforce."],"journal":"J Pharm Policy Pract","authors":["Bukhari, Nadia","Manzoor, Mehr","Rasheed, Huma","Nayyer, Bismah","Malik, Madeeha","Babar, Zaheer-Ud-Din"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32435500","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1186/s40545-020-00215-5","weight":0,"_version_":1667521393844027392,"score":94.42079},{"pmid":32503062,"title":"Will We Miss the Opportunity Again?","text":["Will We Miss the Opportunity Again?","Coronavirus disease 2019 (COVID-19), caused by a new coronavirus, first appeared in late 2019. What initially seemed to be a mild influenza quickly revealed itself as a serious and highly contagious disease, and the planet was soon faced with a significant morbidity and mortality associated with this pathogen. For homeopathy, shunned during its 200 years of existence by conventional medicine, this outbreak is a key opportunity to show potentially the contribution it can make in treating COVID-19 patients. This should be done through performance of impeccably controlled, prospective, randomized clinical trials, with publication of their findings in well-ranked conventional medicine journals. If the homeopathy community fails to take advantage of this rare opportunity, it might wait another century for the next major pandemic.","Homeopathy","Oberbaum, Menachem","32503062"],"abstract":["Coronavirus disease 2019 (COVID-19), caused by a new coronavirus, first appeared in late 2019. What initially seemed to be a mild influenza quickly revealed itself as a serious and highly contagious disease, and the planet was soon faced with a significant morbidity and mortality associated with this pathogen. For homeopathy, shunned during its 200 years of existence by conventional medicine, this outbreak is a key opportunity to show potentially the contribution it can make in treating COVID-19 patients. This should be done through performance of impeccably controlled, prospective, randomized clinical trials, with publication of their findings in well-ranked conventional medicine journals. If the homeopathy community fails to take advantage of this rare opportunity, it might wait another century for the next major pandemic."],"journal":"Homeopathy","authors":["Oberbaum, Menachem"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32503062","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1055/s-0040-1713082","weight":0,"_version_":1668890966391521280,"score":91.53847}]}